Skip to search boxSkip to navigationSkip to main content

Severe thrombocytopenia induced by a occlude for PDA: A medical device surveillance case report

Original title: Trombocitopenia severa inducida por un oclusor para DAP: Reporte de caso en tecnovigilancia
*Corresponding author for this work
  • Instituto Nacional Cardiovascular Carlos Alberto Peschiera Carrillo, EsSalud
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

Spanish

Pages from-to (Number of pages)

Pages 151-154 (4 pages)

Journal (Volume, Issue Number)

Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo (Volume 16, Issue 1)

Publication milestones

  • Published - 01/2023

Publication status

Published - 01/2023

ISSN

2225-5109

Publication IDs

  • Scopus: 85190955751

Abstract

Background: Patent ductus arteriosus (PDA) is a congenital heart condition of special interest. Interventional occlusion is the treatment of choice; however, a PDA occlude, used in this procedure, is a medical device that rarely could lead to adverse events such as hemorrhage, thrombocytopenia, etc. Case report: We present a case of a pediatric patient with severe thrombocytopenia after surgery. During her hospitalization, platelet levels remained lower and, finally, she was fully recovered without any hematological manifestation. The case was reported as a suspected adverse incident related to PDA occlude. Conclusion: After performing a cause-root analysis, we concluded that the size of the PDA occlude may be the main cause of thrombocytopenia. This case demonstrates that medical devices could lead to adverse events. Thus, it is important for clinicians to implement medical device surveillance, mainly for high-risk medical devices.